Skip to content

APOTHEEK VANOVERSCHELDE

Active
Private limited companyfounded 2006active for 20 yearsDorpsstraat 26, 8755 Wingene, BelgiumKBO/BCE: BE 0882.273.297
Summary

APOTHEEK VANOVERSCHELDE has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €312,390 and a net result of €49,565. Equity is growing by about 8.7% per year across the filed financial years. Its solvency ranks better than 74% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK VANOVERSCHELDEActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€515,473total assets 2025
Staff
0.8 FTE
Equity
€312,390
Profit
€49,565
Turnover not published (abbreviated format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Accounts 4 days early1 of 4 deeds read
Why 96raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.50, cash €102,023Equity €312,390 (60.6% of total assets)Founded in 2006Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 67% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 86+2
equity 60.6% of total assets
Liquidity 60-8
short-term debt 33.2% · cash 19.8%
Profitability 81+3
return on assets 9.6%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.5, compared with 2.27 in 2024, above the usual 1.5; short-term debt: 33.2% and cash: 19.8% of total assets), and 39.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 73% on solvency, 67% on liquidity, 73% on profitability and 54% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.50, cash €102,023
NBB · annual accounts
lowers risk · Equity €312,390 (60.6% of total assets)
NBB · annual accounts
lowers risk · Founded in 2006
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
4 days early
2024
7 days late
2023
13 days late
2022
31 days late
2021
33 days early
2020
31 days late
2019
59 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 15 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2018 to 2025net €49,565 ▲34.3%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €49,565 8 years View
  • Board2 directors in office 2 View
  • Total assets 20256 financial years filed €515,473 View

By topic

Financials

Financial year
2025
Total assets
€515,473
Profit
€49,565
Solvency
60.6%
Total assets▲ 2.5%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
  • Dominiek VANOVERSCHELDEDirector
  • VANOVERSCHELDE Veroniek Johanna AlfonsineDirector
Go to Board & ownership

Timeline

Events
24
Since
2008
Next accounts
by 31-07-2027
  1. 13-08-2024Annual accounts filed
  2. 17-11-2023Resignations: Dominiek VANOVERSCHELDE (manager) and Geert VANOVERSCHELDE…
  3. 31-08-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
04-07-2006
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about APOTHEEK VANOVERSCHELDE

What is the company number of APOTHEEK VANOVERSCHELDE?
0882.273.297. In Belgium the VAT number is the company number with BE in front: BE 0882.273.297.
Where is APOTHEEK VANOVERSCHELDE based?
The registered office is at Dorpsstraat 26, 8755 Wingene.Company details
What does APOTHEEK VANOVERSCHELDE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VANOVERSCHELDE?
Private limited company (BV).
When was APOTHEEK VANOVERSCHELDE founded?
On 04-07-2006.
Is APOTHEEK VANOVERSCHELDE still active?
Yes, APOTHEEK VANOVERSCHELDE is an active enterprise in the KBO register.
How many employees does APOTHEEK VANOVERSCHELDE have?
On average 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK VANOVERSCHELDE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK VANOVERSCHELDE profitable?
In financial year 2025, APOTHEEK VANOVERSCHELDE made a profit of €49,565.
Where can I find the annual accounts of APOTHEEK VANOVERSCHELDE?
APOTHEEK VANOVERSCHELDE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VANOVERSCHELDE due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK VANOVERSCHELDE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure